Skip to main content
ISRG logo

ISRG

Compare

Intuitive Surgical Inc

Exchange: NASDAQSector: HealthcareIndustry: Medical Instruments & Supplies

Intuitive, headquartered in Sunnyvale, California, is a global leader in minimally invasive care and the pioneer of robotic surgery. Our technologies include the da Vinci surgical system and the Ion endoluminal system. By uniting advanced systems, progressive learning, and value-enhancing services, we help physicians and their teams optimize care delivery to support the best outcomes possible. At Intuitive, we envision a future of care that is less invasive and profoundly better, where disease is identified early and treated quickly, so that patients can get back to what matters most. About da Vinci Surgical Systems There are several models of the da Vinci Surgical System. The da Vinci surgical systems are designed to help surgeons perform minimally invasive surgery and offer surgeons high-definition 3D vision, a magnified view, and robotic and computer assistance. They use specialized instrumentation, including a miniaturized surgical camera and wristed instruments (i.e., scissors, scalpels, and forceps) that are designed to help with precise dissection and reconstruction deep inside the body. About the Ion Endoluminal System The Ion Endoluminal System (Model IF1000) assists the user in navigating a catheter and endoscopic tools in the pulmonary tract using endoscopic visualization of the tracheobronchial tree for diagnostic and therapeutic procedures. The Ion Endoluminal System enables fiducial marker placement. It does not make a diagnosis and is not for pediatric use. Information provided by the Ion Endoluminal System or its components should be considered guidance only and not replace clinical decisions made by a trained physician.

Did you know?

A large-cap company with a $159.7B market cap.

Current Price

$450.62

-0.95%

GoodMoat Value

$225.00

50.1% overvalued
Profile
Valuation (TTM)
Market Cap$159.74B
P/E55.93
EV$163.53B
P/B8.96
Shares Out354.50M
P/Sales15.87
Revenue$10.06B
EV/EBITDA38.76

Intuitive Surgical Inc (ISRG) Quality Analysis

GoodMoat Analysis

Based on data as of March 26, 2026

Intuitive Surgical exhibits a very strong competitive moat and high-quality financials, with exceptional profitability and returns. However, its current valuation appears extremely demanding, presenting a significant hurdle for a value investor seeking a margin of safety.

Read full analysis
Intuitive Surgical demonstrates a high-quality financial profile, scoring strongly on several key Quality Indicators. The company is exceptionally profitable, with a 28.4% profit margin and a 29.3% operating margin, indicating efficient operations. Its Return on Equity of 16.0% is solid, though it sits just below the framework's high-return threshold of 15-20%. Revenue growth is robust at 18.8% YoY, and the business is firmly GAAP profitable. The lack of debt is a major strength for the balance sheet. However, the Free Cash Flow Yield of 1.5% is low, translating to a high P/FCF multiple, which raises questions about cash generation relative to its market price. This moat is underpinned by several durable advantages from Section 1, including high switching costs for its da Vinci surgical systems, proprietary data from millions of procedures, technology leadership in robotic-assisted surgery, and strategic partnerships within hospital ecosystems. These factors create a wide moat that supports its pricing power and consistent financial performance. Compared to peers in medical devices, Intuitive's profitability and growth profile are superior, but this quality is fully reflected—and arguably overextended—in its current valuation multiples, such as a P/E of 58.3.

ISRG GoodMoat Verdict

Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.

ISRG Profitability

Profitability trend analysis coming soon

ISRG Growth

Growth trend analysis coming soon

ISRG Financial Health

Financial health indicators coming soon

ISRG Quality & Fundamental Analysis

Intuitive Surgical Inc (ISRG) is a Healthcare company in the Medical Instruments & Supplies industry, listed on NASDAQ. This quality analysis page evaluates Intuitive Surgical Inc's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.

Intuitive Surgical Inc has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of 28.38% and a return on equity (ROE) of 16.02%. Return on assets (ROA) stands at 13.96%.

with a current ratio of 4.87. Operating margin is 29.27%.

GoodMoat's quality analysis uses AI-powered insights to evaluate whether Intuitive Surgical Inc is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.